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Important Roles for E Protein Binding Sites within the 
Immunoglobulin 
 

 
 
 
Chain Intronic Enhancer in Activating 
 
V
 

 
J
 

 
 Rearrangement
 
Matthew A. Inlay, Hua Tian, Tongxiang Lin, and Yang Xu
 
Division of Biological Sciences, University of California, San Diego, CA 92093
 
Abstract
 
The immunoglobulin 
 

 
 
 
light chain intronic enhancer (iE
 

 
) activates 
 

 
 rearrangement and is required
to maintain the earlier or more efficient rearrangement of 
 

 
 versus lambda (
 

 
). To understand
the mechanism of how iE
 

 
 regulates 
 

 
 rearrangement, we employed homologous recombination to
mutate individual functional motifs within iE
 

 
 in the endogenous 
 

 
 locus, including the NF-
 

 
B
binding site (
 

 
B), as well as 
 

 
E1, 
 

 
E2, and 
 

 
E3 E boxes. Analysis of the impacts of these muta-
tions revealed that 
 

 
E2 and to a lesser extent 
 

 
E1, but not 
 

 
E3, were important for activating
 

 
 rearrangement. Surprisingly, mutation of the 
 

 
B site had no apparent effect on 
 

 
 rearrangement.
Comparable to the deletion of the entire iE
 

 
, simultaneous mutation of 
 

 
E1 and 
 

 
E2 reduces
the efficiency of 
 

 
 rearrangement much more dramatically than either 
 

 
E1 or 
 

 
E2 mutation
alone. Because E2A family proteins are the only known factors that bind to these E boxes,
these findings provide unambiguous evidence that E2A is a key regulator of 
 

 
 rearrangement.
Key words: B cell development • 
 
V(D)J
 
 recombination • accessibility • monospecificity • 
transcription factor
 
Introduction
 
Each B lymphocyte generates a unique set of immunoglobulin
heavy (IgH) and light (IgL) chain genes through the somatic
rearrangement of 
 
V
 
, 
 
D
 
, and 
 
J 
 
gene segments. To ensure the
monospecificity of each B cell, 
 
V(D)J
 
 recombination is reg-
ulated in such a lineage- and stage-specific manner that IgH
and IgL rearrangement occur at distinct stages of development
(1). Because 
 
V(D)J
 
 rearrangement of all Ig loci involves the
same recombination machinery, cis elements within these
antigen receptor loci must play decisive roles in regulating
the accessibility of each locus to 
 
V(D)J
 
 recombination machin-
ery (2). Within the 
 

 
 locus, several cis-acting elements
were initially identified by their ability to activate transcrip-
tion of 
 

 
 reporter constructs in B cell lines, including two
enhancers, one within the 
 
J
 

 
-
 
C
 

 
 intron (iE
 

 
) and one 3
 

 
 of
 
C
 

 
 (3
 

 
E
 

 
) (3–8). More recently, a putative third enhancer 8
kb downstream of 3
 

 
E
 

 
 (Ed) was also discovered (9). The
deletion of the intronic enhancer and matrix attachment
region (MiE
 

 
) led to decreased 
 

 
 
 
rearrangement and a
lower 
 

 
:
 

 
 ratio. More importantly, MiE
 

 
 is required for the
earlier or more efficient rearrangement of 
 

 
 
 
versus 
 

 
 loci.
(10, 11). The matrix attachment region (MAR) within
MiE
 

 
 does not contribute to these activities since the dele-
tion of the 
 

 
 
 
MAR alone does not have an inhibitory effect
on the overall level of 
 

 
 
 
rearrangement (12). The deletion
of the 3
 

 
 enhancer (3
 

 
E
 

 
) results in a similar, though less
dramatic decrease in the ratio of 
 

 
:
 

 
 B cells and 
 

 
 
 
rearrange-
ment (13). In addition, 3
 

 
E
 

 
 appears to play an important
role in activating 
 

 
 
 
transcription in mature B cells (11, 13).
Although the loss of either enhancer alone does not eliminate
 

 
 
 
rearrangement, deletion of both enhancers from endoge-
nous 
 

 
 
 
loci results in a complete block of 
 

 
 
 
rearrangement
(11). Therefore, MiE
 

 
 and 3
 

 
E
 

 
 together are the necessary
elements for 
 

 
 
 
rearrangement.
Several functional motifs within the intronic enhancer
were identified through a battery of biochemical and cell
line transfection studies. One such functional motif is the
NF-
 

 
B binding site, denoted 
 

 
B (14). The potential role of
the 
 

 
B site in 
 

 
 rearrangement was suggested by the find-
ing that LPS could induce 
 

 
 germline transcription and rear-
rangement through an NF-
 

 
B–dependent pathway (15–
18). iE
 

 
 also contains a class of protein-binding motifs re-
ferred to as E boxes, which are also identified in enhancers
of other antigen receptor genes (19, 20). iE
 

 
 contains three
E boxes, labeled 
 

 
E1, 
 

 
E2, and 
 

 
E3. 
 

 
E2 was found to
bind the E2A gene products E12 and E47, which are re-
quired for B cell development (21–23). E2A gene products
can also bind to 
 

 
E1 but not to 
 

 
E3 (Murre, C., personal
communication). E2A can induce germline transcription
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and 
 

 
 rearrangement when cotransfected with the 
 
RAG
 
genes in a nonlymphoid cell line (24). However, the role of
E2A in the regulation of 
 

 
 rearrangement in the physiolog-
ical context remains unclear.
To delineate the mechanism through which iE
 

 
 activates
 

 
 rearrangement, we employed homologous recombination
and 
 
Cre/loxP
 
-mediated deletion to produce independently
targeted deletions of four functional motifs within the en-
dogenous 
 

 
 intronic enhancer. Analysis of the effects of these
mutations on 
 

 
 rearrangement revealed that the E2A-bind-
ing E boxes, but not the 
 

 
B site, were quantitatively impor-
tant for the activation of 
 

 
 rearrangement. In addition, the
simultaneous mutation of both 
 

 
E1 and 
 

 
E2 sites impacts 
 

 
rearrangement as severely as the deletion of the entire iE,
indicating that E2A-dependent pathways are the major me-
diator of iE’s activity in activating  rearrangement.
Materials and Methods
Generation of mEX Embryonic Stem Cells. The 740-bp  in-
tronic enhancer was cloned into pBluescript. The four sites were
deleted and replaced with diagnostic EcoRI sites independently
by site-directed mutagenesis. The primers used to replace each
site are as follows: mB, 5-TGGCATCTCAACGAATTCA-
GAGCCATCTGG-3; mE1, 5-GACTTTCCGAGAGAAT-
TCAGTTGCTTAAGA-3; mE2, 5-CAGTTCCTCCGAA-
TTCGATTACAG-3; and mE3, 5-TGGCTAAAAATTGA-
ATTCAAACCATTAGAC-3.
The mE1/2 double mutations were generated by PCR-
mediated mutagenesis. The E1 and E2 sequences are as fol-
lows, with the underlined C nucleotides mutated to A: E1,
CATCTGGC; E2, CAGGTGGC. The MiE deletion (mD)
was generated as described (10). All mEX clones were inserted
into the mD targeting construct. 20 g of each targeting con-
struct was linearized with PvuI and transfected into embryonic
stem (ES) cells. Transfectants were selected with G418 (300 g/
ml) and gancyclovir (1 M). Homologous recombination was
screened by Southern blot, and positive clones were then tran-
siently transfected with 10–20 g of a plasmid containing the Cre
gene to remove the PGK-neor gene as described (10). PGK-neor–
deleted ES clones were subcloned, confirmed by Southern blot,
and analyzed by RAG-2–deficient blastocyst complementation as
described (10). mE1/2 ES cells were microinjected into blasto-
cysts before Cre transfection and then bred to Cre-expressing
mice to generate mE1/2 knock-in mice.
Quantitative Analysis of V J Rearrangements. To detect V J
rearrangements, genomic DNA from mature B cells (CD19/
IgM) was purified and amplified by PCR using the degenerate
V primer (VD) (15) and a primer within the kappa intronic en-
hancer (K1). PCR reactions were conducted under the following
conditions: 95C for 5 min, followed by 26 cycles of 94C for 1
min, 60C for 1 min, and 72C for 3.5 min, followed by an addi-
tional 10 min at 72C. To control for the total amount of B cell
DNA used in each PCR reaction, VDJH rearrangement was also
analyzed using a primer for the J558 family (J558) and a primer
that can bind to all four JH gene segments (JH(14)). The in-
tensity of each PCR product was quantified with a Storm phos-
phorimager. Primers used are as follows: VD, 5-GGCTGCAG-
STTCAGTGGCAGTGGRTCWGGRAC-3; K1, 5-CCAT-
GACTTTTGCTGGCTGTAGATTTTACCTC-3; J558, 5-
CTTCAGTGAAGCTGTCCTGCAAGGCTT-3; and JH(14),
5-CAGCTTACCTGAGGAGACGGTGA-3. Hybridomas were
generated and analyzed as described (10). The University of Cali-
fornia, San Diego Animal Subject Committee approved all ex-
periments that involved mice.
Quantitative Analysis of  Transcription by Real-Time PCR. B
cells from the spleens of WT and homozygous mE1/2 mutant
mice were purified by magnetic-activated cell sorting using
CD43 microbeads according to the manufacturer’s protocol
(Miltenyi Biotec). In mE1/2 mutants,  B cells were removed
by costaining with 0.5 g/million cells biotin-conjugated
-mouse Ig antibodies (clone R26-46; BD Biosciences) and then,
after washing, staining with 0.5 g/million cells -biotin micro-
beads (Miltenyi Biotec). RNA from 1 million sorted cells was
purified using the RNAeasy kit (QIAGEN) combined with on-
column DNase digestion (QIAGEN) and converted into cDNA
using the Superscript First Strand System (Invitrogen) according
to the manufacturers’ protocols. Primers for amplifying the con-
stant regions of  (C1 and C2) and  (C1 and C2) were de-
signed using Primer Express software (Applied Biosystems) and
used at concentrations of 200 and 400 nM, respectively. Real-
time PCR reactions were performed using the SYBR Green
PCR Master Mix (Applied Biosystems) in an ABI Prism 7000 Se-
quence Detection System according to the manufacturer’s pro-
tocols. Relative transcription levels were calculated using ABI
Prism 7000 SDS software using the standard curve method. Primer
sequences are as follows: C1, 5-ACACCTGCCGTGTGGA-
TCA-3; C2, 5-GAGGAAGATGTCGGCAAAGG-3; C1,
5-CAACTGTATCCATCTTCCCACCA-3; and C2, 5-
GGCACCTCCAGATGTTAACTGCT-3.
Results and Discussion
Generation of mEX ES Cells. The 740-bp HindIII–
AflII region spanning the  intronic enhancer and associ-
ated matrix attachment region (MiE) was cloned into
pBluescript. The NF-B, E1, E2, or E3 sites were each
individually replaced with a diagnostic EcoRI restriction
site by site–directed mutagenesis (Fig. 1 F). These iE mu-
tants, collectively referred to as mEX and individually as
mB, mE1, mE2, and mE3, were independently in-
serted into the targeting construct used previously to delete
MiE, so that homologous recombination between the tar-
geting vector and the endogenous locus would replace the
endogenous MiE with mEX (10) (Fig. 1 B). Homolo-
gous recombination events were screened by Southern
blotting with EcoRI digestion and hybridization to probe
A (Fig. 1, A and C; not depicted). The PGK-neor gene was
excised from the targeted allele by transient expression of
the Cre gene in positive ES clones (Fig. 1 D). ES clones
with the PGK-neor deleted were subcloned and confirmed
by Southern blot with EcoRI digestion and hybridization
to probe A (Fig. 1 E, lanes 2–5).
Analysis of V J Recombination in mEX B Cells. The
effects of mEX mutations on  rearrangement in B cells
were assayed by recombination activating gene-2–deficient
(RAG-2/) blastocyst complementation as described (10).
Since heterozygous mutant ES cells were used, this enabled
us to compare the rearrangement frequency between the
WT and mutant  alleles. B cells were sorted from mEX–
RAG-2/ mice and analyzed for V J recombination using
Inlay et al. Brief Definitive Report1207
a quantitative PCR assay as previously described (11, 12).
This assay could detect rearrangement to all four functional
J gene segments and distinguish PCR products derived
from the WT allele from those from the mutant allele due to
an additional 150 bp within the mutant allele (Fig. 2 A).
Therefore, the efficiency of V J1-5 rearrangement of the
mutant  allele could be compared with that of the WT al-
lele in the same PCR reaction (Fig. 2 C). Our analysis indi-
cated that neither the NF-B (mB) nor E3 (mE3) site
mutations had any apparent effect on  rearrangement (Fig.
2 B). However, mutation of the E1 (mE1) or E2
(mE2) site reduced the rearrangement efficiency of the mu-
tant  allele. The mutation of the E2 site had a more inhib-
itory effect on  rearrangement (Fig. 2 B, lane 4). In this
context, the ratio of the rearrangement frequency of V to
J1, J2, J4, and J5 gene segments of the mutant allele ver-
Figure 1. Generation of
mEX mutant ES cells. (A) The
endogenous WT  locus. The
lengths of the diagnostic restric-
tion fragments and probes are
shown. Markings above the dia-
gram are spaced 1 kb apart. (B)
The mEX targeting construct.
The mutated intronic enhancer
(*) was inserted into the targeting
construct just upstream of the
loxP-flanked PGK-neor gene.
Additional polylinker sequence
upstream of the mutated intronic
enhancer is represented by a box
with diagonal lines. (C) Targeted
locus with the PGK-neor gene
inserted. Size of the diagnostic
EcoRI fragment is shown. (D)
Final configuration with the
PGK-neor gene removed by Cre/
loxP-mediated deletion. The size
of the EcoRI restriction frag-
ment is shown. (E) Southern
blot analysis of the genomic
DNA from WT ES cells and ES
clones from the final configuration
of each of the four heterozygous
mEX mutants. WT (13.5 kb)
and neor-deleted (9.4 kb) bands
are indicated. (F) Diagram of the
intronic enhancer and its func-
tional motifs. The MAR, B
site, and the three E boxes are
shown. The sequences spanning
each of the four sites that were
replaced by EcoRI sites are
shown in boxes. The consensus
sequences of the each of the four
sites are underlined.
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sus that of the WT allele was 52.1, 31.9, 26.2, and 27.9%, re-
spectively (Fig. 2 C). In mE1 B cells, the rearrangement ef-
ficiency of the mutant allele was approximately twofold
reduced for each of the four possible V J  rearrangements
compared with that of the WT allele (Fig. 2 B, lane 3,
and C).
Analysis of V J  Recombination in mEX  Hybridomas.
To further confirm the impact of mEX mutations on 
rearrangement efficiency and analyze the rearrangement
frequency of mutant and WT alleles in individual B cells,
we generated hybridomas from the spleen cells of all four
mEX–RAG-2/ mice as described (10). Genomic
DNA derived from  hybridomas was analyzed by
Southern blotting to detect V J rearrangements at the
WT and mutant alleles. Consistent with the data from
the PCR analysis, we observed the most dramatic de-
crease in the rearrangement frequency of the mutant al-
lele in mE2 hybridomas (Fig. 3 B). In this context, of
the 67  hybridomas analyzed 48 had rearrangements
on only the WT allele, 10 had rearrangements on only
the mutant allele, and 9 had rearrangements on both al-
leles (Fig. 3 C). The ratio of the rearrangement fre-
quency of the WT allele versus that of the mutant allele
was 3:1. A less dramatic decrease was observed in
mE1 hybridomas (Fig. 3 C). Consistent with the data
derived from the PCR analysis, little difference was de-
tected in the rearrangement frequency of the WT and
mutant alleles in hybridomas derived from the mB and
mE3 B cells (Fig. 3, A and C).
To determine the contribution of the E1 and E2 sites
to the full activity of iE, hybridomas were also generated
from B cells in which the entire intronic enhancer was de-
leted from one allele (mD). Only 3 of 43  mD hy-
bridomas analyzed harbored a V J rearrangement on the
mutant allele, whereas the WT allele was rearranged in all
43 hybridomas (Fig. 3 C). Therefore, the reduction of the
rearrangement efficiency caused by the deletion of the en-
tire iE was much more dramatic than that caused by E1
or E2 mutations alone. In addition, these data indicate
that the rearrangement of the mutant allele occurs only af-
ter the rearrangement of the WT allele in mD B cells.
Critical Roles of E1 and E2 in Mediating iE’s Function in
Activating  Rearrangement. Although the reduction of 
rearrangement caused by the E1 or E2 mutations alone
was significantly less than that caused by the deletion of the
entire enhancer, it is possible that these two sites have re-
dundant functions since both sites can be bound by E2A
family proteins. To test this hypothesis, we mutated both
E1 and E2 sites simultaneously through homologous re-
combination and assayed for effects on  rearrangement.
The mutation introduced at both sites was a single nucle-
otide (C to A) mutation that destroyed the canonical basic
helix-loop-helix binding site (CANNTG) (Fig. 4 A). To
determine the effects of the E1/2 mutation on  rear-
Figure 2. PCR analysis of
V J rearrangement in mEX
heterozygous mice. (A) PCR
strategy. Examples of rearranged
V J1 WT and mEX alleles are
shown. Annealing locations of the
degenerate V  primer and K1
primer are shown with arrow-
heads, and probe B is shown with
a horizontal bar. Markers are placed at 1 kb intervals for scale. (B) Represen-
tative PCR products of the rearrangement assay from B cells of WT and
each of the four mEX heterozygous mutants are shown. Bands correspond-
ing to mutant (mut) and WT V J1, V J2, V J4, and V J5 rearrange-
ments are indicated. Heavy chain rearrangement was also assayed by PCR as
a control for the number of B cells, using primers J558 and JH(14) as de-
scribed (11). Band shown corresponds to rearrangement from J558 VH
family members to either JH1 or JH4 (VDJH). Only the smallest band pro-
duced by this primer set is shown. (C) Statistical analysis of the ratio of the
rearrangement efficiency of mEX allele versus that of the WT allele. Rear-
rangement efficiency was calculated by dividing the intensity of bands
derived from the mutant allele by that of the WT allele. Means values from
at least three independent experiments are presented with error bars. Total
number of mice (n) analyzed for each mutation were; mB (n 	 3), mE1
(n 	 3), mE2 (n 	 5), and mE3 (n 	 2).
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rangement, we used the same PCR assay described in Fig.
2 to analyze  rearrangement of WT and mutant alleles in
 mE1/2 B cells purified from the spleens of RAG/
chimeric mice or heterozygous mutant mice. The reduc-
tion in  rearrangement caused by the mE1/2 mutation
was much more severe than that caused by either E1 or
E2 mutations alone (Fig. 4, B and C). Analysis of  hy-
bridomas derived from mE1/2 B cells revealed a more
than 10-fold reduction in the rearrangement efficiency of
the mutant allele, comparable to that caused by the deletion
of the entire enhancer (Fig. 4 D). In addition, similar to
findings in mD hybridomas, the mE1/2 allele only rear-
ranged after the WT allele had already rearranged.
To rule out the possibility that the greatly reduced rear-
rangement efficiency of mE1/2 alleles observed in splenic
B cells is due to the impaired expression of rearranged  at
mE1/2 alleles during the transition from pre–B cells to im-
mature B cells, we examined the rearrangement frequency
of WT and mutant alleles in pre–B cells (B220/CD43/
IgM) sorted from the BM of mE1/2 mice (Fig. 4 E).
Similar to that observed in splenic B cells, the rearrange-
ment frequency of the mE1/2 allele was significantly re-
duced in pre–B cells compared with the WT allele. To fur-
ther determine whether the mE1/2 mutation affects 
expression in B cells, we analyzed  expression in  B cells
purified from the spleens of WT mice and homozygous
mE1/2 mutant mice. Similar levels of  mRNA were de-
tected in WT and mE1/2  B cells, indicating that the
mE1/2 mutation had no apparent effect on  transcription
(Fig. 4 F). Therefore, E1 and E2 play synergistic roles in
iE’s function in activating  rearrangement.
Sequential rearrangement of the IgH and IgL chain genes
is critical to ensure B cell monospecificity. The  intronic
enhancer plays an important role in this process (10, 11). By
analyzing the functional motifs within iE in vivo, we dem-
onstrated that the B site mutation had no apparent impact
Figure 3. Southern blot analy-
sis of  rearrangement in mEX
hybridomas. Representative data
from mB (A) and mE2 (B) hy-
bridomas. Genomic DNA was
digested with BamHI and hy-
bridized to probe B. Lanes 1, 2,
and 3 on each blot are genomic
DNA from WT ES, mutant ES,
and P3X63 fusion partner, respec-
tively. All other lanes represent
individual  hybridoma lines.
Bands representing germline WT
(12.5 kb) and mutant (9.7 kb)
alleles and the contribution of
the P3X63 fusion partner are in-
dicated. Unspecified bands of
various sizes represent rearranged
alleles. White lines indicate that
intervening lanes have been spliced
out. (C) Analysis of  rearrange-
ment frequency in -expressing
hybridomas. Hybridomas were
scored for rearrangement of the
WT allele, mutant allele, or both
alleles. Rearrangement frequen-
cies are the number of WT or
mutant rearranged alleles divided
by the total number of hybrid-
omas. Rearrangement efficiency
is calculated by dividing the mu-
tant rearrangement frequency by
the WT rearrangement frequency. 
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on  rearrangement. The B site is bound by NF-B family
members and was found to play an important role in activat-
ing  rearrangement of recombination substrates in cell line
transfection and transgenic studies (16, 25). However, the
findings that the impacts of E1 and E2 double mutation
on  rearrangement are very similar to the deletion of the
entire iE rule out any important roles of other protein-
binding motifs within iE, such as the NF-B binding site,
in activating  rearrangement. Based on the findings that iE
and 3E are the essential elements activating  rearrange-
ment and that there is no NF-B binding site within 3E, it
remains unclear how NF-B family transcription factors
might activate  rearrangement. Based on the findings that
NF-B is activated during B cell activation induced by
cross-linking of the antigen receptor (for review see refer-
ence 26), the potential roles of the B site in receptor editing
and somatic hypermutation of  should be examined.
Our findings provide unambiguous evidence that the
E1 and E2 sites play critical roles in activating  rear-
rangement. E2A family transcription factors are the primary
transcription factors binding to the E1/2 sites, and when
coexpressed with the RAG proteins, are able to activate 
Figure 4. Impacts of the E1/
E2 double mutation (mE1/2)
on  rearrangement. (A) South-
ern blotting analyses of mE1/2
heterozygous ES cells. The en-
zymes and probe used are the
same as in Fig. 1. Genomic DNA
derived from WT, PGK-neor–
inserted and PGK-neor–deleted
mE1/2 ES cells are shown in
lanes 1, 2, and 3, respectively.
(B) PCR analysis of V J rear-
rangement at the WT and mutant
alleles. The strategy for the rear-
rangement PCR assay is identical
to that described in Fig. 2. Rep-
resentative data derived from 
splenic B cells from mE1/2–
Rag2/ chimeric mice and het-
erozygous germline mice are
shown in lane 3 and 4, respec-
tively. As PCR controls, PCR
products of genomic DNA de-
rived from WT splenic B cells
and mE3 splenic B cells are
shown in lanes 1 and 2, respec-
tively. (C) Statistical analysis of
the ratio of the rearrangement
frequency of the mutant allele
versus that of the WT allele.
Mean values derived from four
independent experiments are
shown with error bars. (D) Rep-
resentative Southern blotting
analysis of hybridomas derived
from spleen mE1/2 B cells. Total
numbers of the rearranged WT
and mutant allele in 31 hybrid-
omas are shown. White lines in-
dicate that intervening lanes have
been spliced out. (E) PCR analysis
of V J rearrangement of the
WT and mutant allele in mE1/2
pre–B cells (lane 2). As a control,
the rearrangement of WT and
mutant alleles in mE3 splenic
B cells is also shown (lane 1). (F)
Relative  expression in 
B cells derived from WT and
mE1/2 homozygous mutant
B cells.  transcripts were ana-
lyzed by quantitative real-time
PCR. mRNA levels were nor-
malized to  expression. Average
of three RNA purifications are
shown with error bars.
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rearrangement in a non–B cell line (24). Therefore, our
findings provide a mechanism for how E2A family tran-
scription factors might function in activating  rearrange-
ment. Based on the findings that E2A can interact with his-
tone acetyltransferases such as p300/CBP and the SAGA
complex (27–29), E1/2 might activate  rearrangement
by increasing histone acetylation of the  locus.
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